ML-281

SynDRA canonical compound SYN0062929 — structure-anchored drug synonym record

Clinical phase	Preclinical
Primary target(s)	STK33
Mechanism of action	serine/threonine kinase inhibitor

Cross-references

PubChem CID: 53377448
ChEMBL: CHEMBL2204239
ChEBI: 125325
LINCS BRD: BRD-K48188942

Synonyms

ML281
MFCD25976601
bg-stk33-59
MLS003876599
orb1304214
SCHEMBL28712145
SCHEMBL30239895
SCHEMBL31580984
BRD8942
EX-A996
CHEBI:125325
BRD-8942
EGC43762
BDBM50400664
ML281?
AKOS024458394
CS-5682
NCGC00379225-02
AC-30951
BS-15376
DA-55534
HY-13495
SMR002533153
F861829
BRD-K48188942-001-01-1
N-[2-(3-oxo-4H-quinoxalin-2-yl)-4-propan-2-ylphenyl]-2-thiophenecarboxamide

Look up ML-281 in the interactive SynDRA portal →